BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, introduces its new Mobius CellReady 3L Bioreactor. Co-developed under an agreement with Applikon Biotechnology, this ready-to-use three liter bioreactor requires no incremental capital investment, eliminates downtime and increases efficiency during process development.
